Clinical Trials in France — Country Dashboard | 4,499 EU Studies

Filter these 4,499 trials by condition, phase, sponsor and more.

Open in Search →

4,499 Registered trials

1,852 Recruiting

2,147 Completed trials

906 Sponsors active

1,196 Research sites

Phase III

Phase II

Phase III: 1870 Phase II/III: 208 Phase II: 1264 Phase I/II: 286 Phase III/IV: 51 Phase IV: 173 Phase I: 239 Phase I (Other): 177 Phase I (FiH): 218 Other: 8 Other: 5

Oversight events in trials active here:

104 serious breaches 883 temporary halts 92 urgent safety measures 105 unexpected events 179 corrective measures across 542 trials

View oversight register →

Top conditions

Non-small cell lung cancer 154 Non-small cell lung cancer metastatic 52 Colorectal cancer 39 Ovarian cancer 37 Squamous cell carcinoma of head and neck 32 Systemic lupus erythematosus 30 Endometrial cancer 28 Breast cancer 28 Non-small cell lung cancer stage IV 27 Myelodysplastic syndrome 27 Diffuse large B-cell lymphoma 26 Triple negative breast cancer 26

Top sponsors

Assistance Publique Hopitaux De Paris 264 Centre Hospitalier Universitaire De Nantes 195 Merck Sharp & Dohme LLC 178 Novartis Pharma AG 165 F. Hoffmann-La Roche AG 144 AstraZeneca AB 142 Janssen - Cilag International 115 AbbVie Deutschland GmbH & Co. KG 97 Sanofi-Aventis Recherche & Developpement 72 Glaxosmithkline Research & Development Limited 66 Bristol-Myers Squibb Services Unlimited Company 65 Unicancer 65

Cities with most trials

All 448 cities →

All trials — page 62

4,499 total

A clinical trial to evaluate the safety and the efficacy of NEXAGON ® (Lufepirsen Ophthalmic Gel) in subjects with Persistent Corneal Epithe… Recruiting

2023-507030-24-00 Phase II Persistent Corneal Epithelial Defects Glaukos Corp.
Is CT 01 safe to use alone or combined with Everolimus for inoperable advanced liver cancer? Recruiting

2024-511435-10-00 Phase I Hepatocellular Carcinoma Captor Therapeutics S.A.
MODULO Recruiting

2024-515793-27-01 Phase III HIV ANRS Maladies Infectieuses Emergentes; Centre De Recherches Et D'Etudes Sur La P…
A study of elritercept to treat transfusion-dependent anemia due to very low, low, or intermediate risk myelodysplastic syndromes Recruiting

2024-516009-22-00 Phase III myelodysplastic neoplasms/syndromes (MDS) Takeda Development Center Americas Inc.
Phase 3 study of belantamab mafodotin, lenalidomide, and dexamethasone (BRd) versus daratumumab, lenalidomide, and dexamethasone (DRd) in pa… Recruiting

2024-516030-35-00 Phase III Multiple myeloma Glaxosmithkline Research & Development Limited
Randomized clinical trial to compare oral isotretinoin to standard of care in moderate acne skin of color patients Recruiting

2023-507519-36-00 Phase III Acne Centre Hospitalier Universitaire De Nice
Corticodependent or corticoresistant brain radionecrosis after radiotherapy for brain metastases: a multicentre randomized, controlled doub… Recruiting

2024-510893-25-00 Phase III Brain metastases of cancer > brain radionecrosis Institut De Cancerologie De L Ouest
A study to assess the effectiveness and safety of pacritinib in patients with VEXAS syndrome (PAXIS) Recruiting

2024-516347-41-00 Phase II VEXAS Syndrome Sobi Inc.
A First-in-Human Study to Test the Safety and Effects of the Investigational Drug IPH4502 in People with Advanced Cancers Recruiting

2024-519162-46-00 Phase I Advanced Solid Tumors Innate Pharma
Study of Intravenous Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor to Assess Adverse Events and Change in … Recruiting

2024-514465-18-00 Phase I/II Advanced or Metastatic Non-Squamous NSCLC AbbVie Deutschland GmbH & Co. KG
Management of moderate to severe monotraumatic pain with sublingual Sufentanil in an emergency situation. Recruiting

2024-519217-64-00 Phase IV trauma to the lower or upper limb University Hospital Of Clermont-Ferrand
Evaluation of the real-life efficacy, safety, and immunogenicity of chikungunya vaccination in populations at risk of severe or complicated … Recruiting

2025-521307-43-00 Phase IV Infectious disease: Chikungunya Centre Hospitalier Universitaire De La Reunion
A Phase 3 Study of a GPRC5D-directed CAR T Cell Therapy in Participants with Relapsed or Refractory Multiple Myeloma and Exposed to Lenalido… Recruiting

2024-515279-37-00 Phase III Relapsed or Refractory and Lenalidomide exposed Multiple Mye… Celgene Corp.
Evaluation of the safety of a strategy combining etanercept administration with repeated contrast ultrasound in patients with Alzheimer's d… Recruiting

2023-505714-19-00 Phase I (Other) Alzheimer's disease Hopital Fondation Adolphe De Rothschild
Effect of low-dose arginine-vasopressin supplementation on post-transplant Acute Kidney Injury after liver transplantation - AVENIR Trial Recruiting

2023-506512-40-00 Phase III Acute Kidney Injury Assistance Publique Hopitaux De Paris
A Worldwide Study Testing the New Drug Olverembatinib for Patients with Chronic Phase Chronic Myeloid Leukemia (POLARIS-2) Recruiting

2024-511495-32-00 Phase III Chronic Phase Chronic Myeloid Leukemia Ascentage Pharma Group Inc.
A Study to Test the Effectiveness and Safety of RO7790121 for induction and maintenance therapy in Patients with Moderately to Severely Acti… Recruiting

2024-513053-69-00 Phase III Moderately to Severely Active Crohn's Disease (CD) F. Hoffmann-La Roche AG
A Study to Assess the Effectiveness and Safety of Induction Therapy with RO7790121 in Participants with Moderately to Severely Active Crohn'… Recruiting

2024-513054-30-00 Phase III Moderately to Severely Active Crohn's Disease (CD) F. Hoffmann-La Roche AG
Effect of Carvedilol on the portosystemic gradient as measured by endoscopic ultrasound Recruiting

2024-518302-41-00 Phase II cirrhotic portal hypertension University Hospital Of Clermont-Ferrand
Evaluation of the benefits of Administering immunosuppressive drugs as Single daily doses over the first Year after liver transplantation Recruiting

2023-506601-19-00 Phase IV transplantation Centre Hospitalier Universitaire De Limoges
Addition of sulfalasazine to chemotherapy for the treatment of AML in the elderly Recruiting

2024-513084-38-00 Phase I/II Recently diagnosed non favorable Acute Myeloid Leukemias Assistance Publique Hopitaux De Paris
A trial to learn how well surovatamig (AZD0486) works and how safe it is in adults with certain blood cancers Recruiting

2023-505789-27-00 Phase II Relapsed or Refractory Non-Hodgkin Lymphoma Astrazeneca AB
Prevention of HEMOrhagic risk in upper MYOmeCTomy by use of Misoprostol. Recruiting

2024-513617-13-00 Phase II fibroma University Hospital Of Clermont-Ferrand
Best hypnotic drug choice for rapid sequence induction in the operating room: a 3-arm randomized trial open-labelled with blinded evaluation… Recruiting

2024-517582-16-00 Phase III rapid sequence induction in the operating room Centre Hospitalier Universitaire De Nantes

Showing 1,465–1,488 of 4,499 trials

← All countries